Drug Profile
Research programme: ethinylestradiol prodrugs - Evestra
Alternative Names: EVE-106Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Evestra
- Class Estradiol congeners
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for preclinical development in Pregnancy(Prevention) in USA
- 01 Jan 2014 Preclinical trials in Pregnancy (Prevention) in USA (unspecified route)